We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current IOVA market cap is 2.28B. The company's latest EPS is USD -1.4569 and P/E is -5.10.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 238k | 469k | 482k | 715k | 31.11M |
| Operating Income | -110.09M | -118.36M | -121.26M | -117.72M | -101.91M |
| Net Income | -106.53M | -113.76M | -116.38M | -112.98M | -97.1M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 1.19M |
| Operating Income | -206.87M | -261.94M | -342.7M | -398.88M | -460.56M |
| Net Income | -197.56M | -259.58M | -342.25M | -395.89M | -444.04M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 757.29M | 852.32M | 780.35M | 869.83M | 964.32M |
| Total Liabilities | 178.72M | 178.31M | 195.74M | 189.81M | 195.78M |
| Total Equity | 578.57M | 674.01M | 584.61M | 680.02M | 768.54M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 344.66M | 768.46M | 777.33M | 663.98M | 780.35M |
| Total Liabilities | 45.68M | 111.96M | 155.67M | 164.34M | 195.74M |
| Total Equity | 298.97M | 656.5M | 621.66M | 499.64M | 584.61M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -193.77M | -277.85M | -361.82M | -122.28M | -220.71M |
| Investing | -3.38M | -82.4M | -155.24M | -111.51M | -71.29M |
| Financing | 259.2M | 462M | 462.96M | 193.58M | 346.4M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -158.89M | -205.13M | -227.94M | -292.76M | -361.82M |
| Investing | 90.03M | -317.85M | 132k | 256.46M | -155.24M |
| Financing | 6.13M | 576.42M | 239.27M | 190.15M | 462.96M |
| Market Cap | 2.28B |
| Price to Earnings Ratio | -5.10 |
| Price to Sales Ratio | 1.91k |
| Price to Cash Ratio | 19.71 |
| Price to Book Ratio | 3.87 |
| Dividend Yield | - |
| Shares Outstanding | 304.78M |
| Average Volume (1 week) | 7.9M |
| Average Volume (1 Month) | 5.5M |
| 52 Week Change | -12.43% |
| 52 Week High | 18.33 |
| 52 Week Low | 6.70 |
| Spread (Intraday) | 0.01 (0.13%) |
| Company Name | Iovance Biotherapeutics Inc |
| Address |
2140 s dupont hwy camden, delaware 19934 |
| Website | https://www.iovance.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
